The Autopsy / Case File · Overdose & Substance
Still Paraphernalia
A fentanyl test strip costs about a dollar, takes three minutes, and can tell someone whether the pill or powder they're about to use contains the drug responsible for the overwhelming majority of the country's overdose deaths. In Texas, Idaho, Indiana, Iowa, and North Dakota, possessing one is still, on paper, a crime.
Forty-five states plus Washington, D.C. have removed fentanyl test strips from their legal definition of drug paraphernalia since 2019, most of that movement compressed into the last four years. The remaining five states haven't run out of time to act — Texas's version of the bill has now failed in the state Senate three legislative sessions in a row, passing the House unanimously each time. The gap between "legal to test" and "still paraphernalia" isn't abstract: fentanyl and other synthetic opioids were involved in 88% of the nation's opioid overdose deaths in 2024, per provisional CDC data — the same drug a person in five states can still be charged for trying to detect.
Join the discussion →
The mechanics of a fentanyl test strip are almost aggressively simple. A small amount of a drug is dissolved in water, the strip is dipped in for about fifteen seconds, and after three minutes it displays either one red line (positive for fentanyl) or two (negative). Originally designed to detect fentanyl in urine for medical and workplace drug screening, the strips were repurposed by harm-reduction programs starting around 2016 as fentanyl began saturating the illicit heroin, cocaine, and counterfeit-pill supply — often undetectable by sight, taste, or smell, and lethal in doses too small to see. The technology didn't change. What has changed, slowly and unevenly, is whether the law in a given state treats a strip of reactive paper as a legitimate safety tool or as the same category of object as a needle used to inject drugs.
Forty-Five States, and a Stubborn Five
The Network for Public Health Law has tracked the legality of drug-checking equipment state by state since fentanyl test strips first drew legislative attention, publishing an updated 50-state survey as recently as September 2025. Their count: 45 states plus the District of Columbia have now enacted some form of exemption removing fentanyl test strips from their drug paraphernalia statutes, whether through a strip-specific carve-out, a broader drug-checking-equipment exemption, or — in states like New Mexico, Wisconsin, Tennessee, and Alabama — dedicated legislation passed in the years since 2021. Ohio took a different, faster route in October 2025: rather than wait on its legislature, Governor Mike DeWine signed an executive order authorizing the State Board of Pharmacy to adopt an emergency rule exempting not just fentanyl test strips but also xylazine, medetomidine, nitazene, and benzodiazepine test strips from the paraphernalia definition — a regulatory fix that can move in weeks instead of the multi-year legislative fights other states have run.
Idaho, Indiana, Iowa, North Dakota, and Texas have had no equivalent breakthrough. Texas is the most-watched holdout precisely because it has come closest to changing course without actually doing so: House Bill 1644, sponsored by Republican state Rep. Tom Oliverson and carrying bipartisan support plus a prior endorsement from Governor Greg Abbott, passed the Texas House by a unanimous 145-0 vote in 2025. It never received a hearing in the state Senate, where Lt. Gov. Dan Patrick controls which bills reach the floor — the third consecutive legislative session in which a Texas fentanyl-test-strip bill has passed the House and died without a vote in the Senate. The stated objection, echoed by paraphernalia-law holdouts elsewhere, is that legalizing a tool for checking drugs before use amounts to condoning drug use. Harm-reduction researchers and legislators who've watched the same argument fail to move Senate leadership across three sessions now frame it differently: the strip doesn't create the decision to use a drug that's already been decided on. It only changes what the person deciding knows about what's actually in it.
What the Strip Actually Changes
The case for legalizing test strips doesn't rest only on the argument that people should have accurate information about a substance they're about to use — it rests on a small but consistent body of published research measuring what people actually do with that information. A 2019 study published in the International Journal of Drug Policy, led by researcher Nicholas Peiper and covering participants at a syringe services program in the southeastern United States, found that receiving a fentanyl-positive test-strip result was associated with roughly five times higher odds of a person reporting a subsequent harm-reduction behavior — using a smaller amount, using more slowly, using with someone else present, or having naloxone on hand during use — compared to those who didn't test or tested negative. A separate survey of participants in Rhode Island's harm-reduction network found that a substantial share of people who used test strips reported discarding a batch entirely after a positive result, using with someone else present specifically because of that result, or making sure naloxone — the opioid-overdose reversal drug — was accessible before using. Surveys from North Carolina and South Carolina harm-reduction programs found comparable patterns: in one, roughly three in four respondents said test strips helped them feel they could protect themselves from an overdose; in another, users reported using smaller amounts, or in some cases not using the tested batch at all.
None of that research claims fentanyl test strips are a solution to the overdose crisis on their own, and the researchers behind these studies are generally explicit that they aren't. What the studies document is narrower and more specific: a person who learns, three minutes before using a drug, that it contains fentanyl is measurably more likely to take a concrete step — smaller dose, present witness, naloxone on hand — that reduces the odds that dose kills them. That's the entire mechanism a $1 strip of paper offers. Whether a given state's law lets someone access it without risking a paraphernalia charge is, at that point, less a public-health question than an administrative one — and in five states, the administrative answer is still no.
The strip doesn't put fentanyl in the drug supply. It tells someone it's already there — three minutes before they'd otherwise find out the only other way anyone finds out.
Why "45 States" Understates the Patchwork
Even the majority of states that have acted haven't necessarily acted the same way, which matters for anyone actually trying to access a strip. The Legislative Analysis and Public Policy Association's state-by-state tracking distinguishes between several distinct legal postures: some states exempt fentanyl test strips specifically, by name, and leave every other kind of drug-checking equipment — strips for xylazine, benzodiazepines, or other adulterants now spreading through the supply — still technically classified as paraphernalia. Others exempt a broader category of "drug checking equipment" that covers strips regardless of which substance they detect. A smaller number restrict legal distribution to licensed syringe services programs or harm-reduction organizations, meaning a strip is legal in the hands of an outreach worker but not necessarily in a pharmacy, a gas station, or a stranger's backpack. Pennsylvania sits in an unusual middle position: state law still technically bans the strips, but Philadelphia and Pittsburgh prosecutors have adopted local non-enforcement policies — a strip that's a felony risk on paper in one part of the state carries essentially no prosecutorial risk in its two largest cities.
That variation means the honest answer to "are fentanyl test strips legal here" is rarely a clean yes or no, even in states counted among the 45. It's legal for whom, distributed by whom, and covering which specific substances — three separate questions that a person deciding whether to carry a strip in their pocket has to answer correctly, in real time, with no formal notice of which answer applies where they're standing.
The Federal Backdrop That Hasn't Moved
No federal fix has consolidated the state patchwork. The federal Controlled Substances Act's paraphernalia provisions leave drug paraphernalia law almost entirely to the states, which is precisely why the legal status of an identical strip of paper varies by which side of a state line it's carried across. Legislation has been introduced in Congress along these lines — Sen. Cory Booker and colleagues have proposed federal measures aimed at expanding test-strip access nationally, and U.S. Reps. Jasmine Crockett and Sheila Cherfilus-McCormick introduced a bill explicitly aimed at removing federal paraphernalia ambiguity around drug-checking equipment — but neither has become law, and neither would automatically preempt a state's own paraphernalia statute even if it did. Absent federal action, the 45-state versus 5-state split is likely to persist exactly as it has for the last several years: driven state by state, sometimes by legislature, sometimes — as Ohio demonstrated — by a governor and a pharmacy board willing to move faster than a legislature that hasn't.
And Then You're Dead
Nobody's overdose death certificate lists a state paraphernalia statute as a contributing factor. It lists fentanyl, or fentanyl analog, the same two words on a death certificate in Ohio as in Texas. The difference between those two states isn't in what killed the person — it's in whether the state let them find out, three minutes ahead of time, that it was there at all.
That's it. That's the whole thing.
Read about xylazine, the sedative fentanyl test strips can't detect · or see every case file
Sources
- The 45-state-plus-D.C. count of jurisdictions exempting fentanyl test strips from drug paraphernalia law, and the 5 remaining states (Idaho, Indiana, Iowa, North Dakota, Texas) — Network for Public Health Law, "Legality of Drug Checking Equipment in the United States," 50-state survey, updated September 2025
- The 88% share of 2024 opioid overdose deaths involving fentanyl or other synthetic opioids, and the 80,499 total 2024 provisional overdose death count — CDC National Center for Health Statistics, Vital Statistics Rapid Release, Provisional Drug Overdose Death Counts
- Texas House Bill 1644's unanimous 145-0 House passage and third consecutive session dying without a Senate hearing — KSAT, "Attempt to decriminalize fentanyl testing strips in Texas could stall in the Senate for a third time," May 7, 2025; Texas Legislature Online bill history for HB 1644, 89th Legislature
- Ohio's October 2025 executive order and Board of Pharmacy emergency rule exempting fentanyl, xylazine, medetomidine, nitazene, and benzodiazepine test strips from paraphernalia law — Ohio Board of Pharmacy, "Governor DeWine Authorizes the Ohio Board of Pharmacy to Adopt Emergency Rule Legalizing Tools to Prevent Drug Overdoses," October 3, 2025
- The five-fold higher odds of a harm-reduction behavior following a fentanyl-positive test-strip result — Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE, "Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the southeastern United States," International Journal of Drug Policy, 2019;63:122-128
- State-by-state variation in which drug-checking equipment is exempted and by whom it may be distributed — Legislative Analysis and Public Policy Association, "Drug Checking Equipment, Needles/Syringes, and Drug Paraphernalia: Summary of State Laws"
- Pennsylvania's statewide ban alongside Philadelphia and Pittsburgh non-enforcement policy, and North Carolina/South Carolina survey findings on self-reported protective behavior after test-strip use — KFF Health News, "As Overdoses Soar, More States Decriminalize Fentanyl Testing Strips"
Photo: "Fentanyl-test-strip.jpg," by WikiLinuz, via Wikimedia Commons (CC BY-SA 4.0).
Comments
Loading…